Preprocedural neutrophil-to-albumin ratio predicts survival in patients undergoing tunneled hemodialysis catheter
Abstract
Aim This study aimed to evaluate the impact of preprocedural neutrophil-to-albumin ratio (NAR) on survival among patients undergoing tunneled hemodialysis catheter (THC) placement.Methods We retrospectively reviewed 60 consecutive patients who underwent right-internal-jugular THC placement between July 2021 and October 2023. Demographics, laboratory variables and survival were collected. NAR and neutrophil-percentage-to-albumin ratio (NPAR) were calculated. Cox regression and Kaplan – Meier analyses explored associations with mortality; receiver-operating-characteristic (ROC) curves defined optimal cutoffs.Results Mean age was 70 ± 12 years; 24 patients (40%) died, yielding one-year survival of 62.5%. On multivariate Cox regression analysis, after adjustment for all covariates, higher NAR remained an independent predictor of mortality (p 175.4 had markedly lower one-year survival than those below the threshold (30.2% vs 88.2%, p
Fields of Study & Subjects
Inflammatory Biomarkers in Disease Prognosis
Dialysis and Renal Disease Management
Central Venous Catheters and Hemodialysis
Publication details
- Journal / source
- Biomarkers in Medicine
- Publisher
- Informa UK Limited
- Volume
- 20
- Issue
- 3
- Pages
- 149–157
- Publication date
- 6 February 2026
- Language
- EN